❓️A long‑debated #melanoma question just got a definitive answer.
In @TheLancetOncol, Dr. @AlexVarey (@MelanomaAus) reported that sentinel node #biopsy isn’t just a staging tool—it’s tied to lower melanoma‑specific mortality & recurrence.
Learn more➡️https://t.co/p21uvvJVWE
Doggy danger: seems that if you’re in First on @AmericanAir you can carry a dog on the plane and block the exit of fellow passengers. Air steward said it wasn’t safe but she just let it go. I’m sure the @NTSB wouldn’t be happy??
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator | Journal of Clinical Oncology https://t.co/VBct7ZSeJb
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator | Journal of Clinical Oncology https://t.co/VBct7ZSeJb
New MIA #RiskCalculatorTool for clinicians with Stage II #melanoma patients. Online tool calculates risk of recurrence & overall survival, enabling more informed management decisions, such as whether to have adjuvant immunotherapy. View this & other tools> https://t.co/Z4SFv1aSNx
Seems fitting to share our latest paper on sentinel node biopsy in melanoma in the era of modern adjuvant systemic therapy - the topic has been repeatedly discussed at #SSO2023 conference here in #Boston Link to paper: https://t.co/DMhN64qMMf
#MIA#melanoma#sentinelnodebiopsy
"We welcome #Budget2023 anncmt of $14.8m over 4 yrs for MIA to develop National Melanoma Nurse Network. 1 of 25 recs in #StateOfTheNation report, 1st to have gov funding. Look forward to working with Fed Gov & other orgs to benefit #melanoma patients/families.” Matthew Browne CEO
Congratulations to Prof John Thompson AO – an outstanding surgical oncologist whose academic record is virtually unparalleled in the field. Many thousands of lives have been saved thanks to his brilliance.
@dfat What’s happening with new passports? Waiting six weeks now but no news and unable to speak to anyone - call waiting disconnects me every time, sometimes after 33 mins waiting on the line. Apparently service is too busy. This is really poor service.
Most patients with a thin melanoma have excellent prognosis, but not all. Thanks to a new online risk calculator developed by MIA clinicians can now calculate the likelihood a patient’s thin melanoma will spread.
See: https://t.co/V0esnqsmQ6
#riskcalculator#melanoma
#optus terrible customer service again. No NBN for 3 days. Help desk says you need to use messenger via their app. Wait 20 mins for response on that then app stops working and says they are updating it.
Congrats to @AnneECust , @SerineLo and @AlexVarey & their teams for bringing the MIA Melanoma Risk Calculators to realisation. Have you checked your melanoma risk? https://t.co/Z4SFv1stF5